DingZ., GeorgievP., and ThönyB. (2006). Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer. Gene Ther., 13, 587–593.
2.
DingZ., HardingC.O., RebuffatA., et al. (2008). Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system. Mol. Ther., 16, 673–681.
3.
FangB., EisensmithR.C., LiX.H., et al. (1994). Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther., 1, 247–254.
4.
NagasakiY., MatsubaraY., TakanoH., et al. (1999). Reversal of hypopigmentation in phenylketonuria mice by adenovirus-mediated gene transfer. Pediatr. Res., 45, 465–473.
5.
ViecelliH.M., HarbottleR.P., WongS.P., et al. (2014). Treatment of phenylketonuria (PKU) using minicircle-based naked-DNA gene transfer to murine liver. Hepatology. [Epub ahead of print]; DOI: 10.1002/hep.27104.
